Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative propranolol and etodolac for colorectal cancer surgery (COMPIT2)
MOH_2018-02-04_002156Phase 3Recruiting
- Sponsor
- פרופסור עודד זמורה
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in colorectal cancer (CRC), colon cancer and rectal cancer comparing Propranolol + etodolac with Placebo (2 arms). Started Dec 2017; status: recruiting.
02
Drugs
propranololetodolac
03
Conditions
colorectal cancer (CRC)colon cancerrectal cancer
Beyond the preview
Go deeper on MOH_2018-02-04_002156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-02-04_002156.